Our Director, Dr Nina Fuller-Shavel, has recently co-authored a review paper with Dr Jonathan Krell, consultant medical oncologist at Imperial College London and HCA, on ‘Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours’. In this blog Dr Nina summarises the paper, including some key actions people treated with immune checkpoint inhibitors can take to support their treatment and wellbeing.